Cite
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
MLA
Schmidt, Amand F., et al. “PCSK9 Genetic Variants and Risk of Type 2 Diabetes: A Mendelian Randomisation Study.” The Lancet Diabetes and Endocrinology Vol.5 (2017) Nr.2 p.97-105 [ISSN 2213-8587], 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1445803840&authtype=sso&custid=ns315887.
APA
Schmidt, A. F., Swerdlow, D. I., Holmes, M. V., Patel, R. S., Fairhurst-Hunter, Z., Lyall, D. M., Hartwig, F. P., Horta, B. L., Hyppönen, E., Power, C., Moldovan, M., van Iperen, E. P., Hovingh, G. K., Demuth, I., Norman, K., Steinhagen-Thiessen, E., Demuth, J., Bertram, L., Liu, T., … LifeLines Cohort Study Group. (2017). PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. The Lancet Diabetes and Endocrinology Vol.5 (2017) Nr.2 p.97-105 [ISSN 2213-8587].
Chicago
Schmidt, Amand F., Daniel I Swerdlow, Michael V Holmes, Riyaz S. Patel, Zammy Fairhurst-Hunter, Donald M Lyall, Fernando Pires Hartwig, et al. 2017. “PCSK9 Genetic Variants and Risk of Type 2 Diabetes: A Mendelian Randomisation Study.” The Lancet Diabetes and Endocrinology Vol.5 (2017) Nr.2 p.97-105 [ISSN 2213-8587]. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1445803840&authtype=sso&custid=ns315887.